Updated 29 August 2025 at 12:15 IST

Anlon Healthcare IPO Day 3: Check Latest GMP, Price Band, Subscription Status & More

Anlon Healthcare’s ₹121.03 crore IPO closed today with strong demand, particularly from retail investors who subscribed 32.78 times. The IPO, priced at ₹86–₹91 per share, is expected to list on BSE and NSE on September 3, 2025. Grey market premium (GMP) signals a likely 5% listing gain.

Follow : Google News Icon  
IPO
IPO | Image: Shutterstock

Anlon Healthcare Ltd.’s ₹121.03 crore initial public offering (IPO) closed for subscription on August 29, 2025, attracting robust investor interest.

According to NSE data, the IPO was subscribed 4.75 times overall, with the retail category seeing the highest demand at 32.78 times.
The Qualified Institutional Buyers (QIB) portion was subscribed 1.01 times (excluding anchor investors), while the Non-Institutional Investors (NII) category witnessed 4.72 times subscription as of 11:54 AM on Day 3.

The issue comprises a fresh issue of 1.33 crore shares, with no offer-for-sale component.

Anlon Healthcare IPO Price Band, Lot Size, and Investment
The price band was fixed at Rs 86–91 per share, with a lot size of 164 shares. The minimum retail investment stood at 14,924, while small NIIs were required to bid for 14 lots (₹2,08,936) and big NIIs for 68 lots (₹10,14,832).
Interactive Financial Services Ltd. acted as the book running lead manager, and Kfin Technologies Ltd. was the registrar of the issue.

Anlon Healthcare IPO GMP Today

According to market tracker websites, Anlon Healthcare’s IPO was commanding a grey market premium (GMP) of Rs 5 as of 10:58 AM on August 29, 2025. Based on the upper price band of ₹91, the expected listing price is Rs 96, indicating a potential 5.49% gain for investors.

Advertisement

About Anlon Healthcare 
Founded in 2013, Anlon Healthcare Ltd. is engaged in the manufacturing of pharmaceutical intermediates and active pharmaceutical ingredients (APIs). The company caters to the pharma, nutraceutical, personal care, and veterinary sectors, adhering to global pharmacopeia standards such as IP, BP, EP, JP, and USP.
Its portfolio includes high-purity pharmaceutical intermediates used in API production and APIs used in medicines, nutraceuticals, personal care products, and animal health formulations.

Read More - PM Modi In Tokyo As Japan Invests Over 3.3 Lakh Crore In India

Anlon Healthcare IPO Listing Date 
The basis of allotment for Anlon Healthcare IPO will be finalized on September 1, 2025, with shares expected to list on the BSE and NSE on September 3, 2025.

Published By : Gunjan Rajput

Published On: 29 August 2025 at 12:15 IST